Olema Pharmaceuticals OLMA
NASDAQ OLMA
$8.23 -0.04 (-0.48%)
At close: Oct 2, 2026 · 4:00 PM EDT

Olema Pharmaceuticals (OLMA) Selling, General & Administrative (2020 - 2026)

Updated

Olema Pharmaceuticals' Selling, General & Administrative came in at $9.39 million for Q2 2026, up 137.1% from $3.96 million a year earlier and up 7.3% from the prior quarter.

Analysis

Olema Pharmaceuticals (OLMA) Selling, General & Administrative (2020 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Olema Pharmaceuticals reported Selling, General & Administrative of $30.94 million, up 81.2% year-over-year; for FY2025, it was $21 million, up 18.4% from FY2024.

  • Selling, General & Administrative carries a five-year compound annual growth rate of 21.8% (FY2020 to FY2025).
  • Going back by year, Selling, General & Administrative was $17.74 million in FY2024 (-5.7%), $18.82 million in FY2023 (-23.8%), $24.71 million in FY2022 (+21.2%) and $20.39 million in FY2021 (+160.6%).
  • The Q2 2026 figure represents the highest quarterly Selling, General & Administrative in data going back to Q1 2020.
  • Year-over-year, Selling, General & Administrative has increased for four consecutive quarters, with growth averaging 41.0% over the last eight quarters.
  • The fastest year-over-year change in Selling, General & Administrative over five years came in Q2 2026 (growth of 137.1%), and the weakest in Q2 2023 (a decline of 42.1%).
  • Business Quant data shows OLMA's Selling, General & Administrative at $8.75 million (Q1 2026), $6.86 million (Q4 2025) and $5.93 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) SG&A (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 3.43 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 6.43 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 3.63 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 2.90 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -3.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn -5.65 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 1.75 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn 1.92 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 3.41 Bn
10 Olema Pharmaceuticals 719.73 Mn 719.73 Mn - 9.39 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 9.39 Mn
Mar 31, 2026 8.75 Mn
Dec 31, 2025 6.86 Mn
Sep 30, 2025 5.93 Mn
Jun 30, 2025 3.96 Mn
Mar 31, 2025 4.25 Mn
Dec 31, 2024 4.47 Mn
Sep 30, 2024 4.40 Mn
Jun 30, 2024 4.42 Mn
Mar 31, 2024 4.46 Mn
Dec 31, 2023 4.54 Mn
Sep 30, 2023 3.89 Mn
Jun 30, 2023 3.61 Mn
Mar 31, 2023 6.78 Mn
Dec 31, 2022 5.64 Mn
Sep 30, 2022 5.60 Mn
Jun 30, 2022 6.24 Mn
Mar 31, 2022 7.25 Mn
Dec 31, 2021 5.78 Mn
Sep 30, 2021 5.24 Mn
API Access

Olema Pharmaceuticals Selling, General & Administrative API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=OLMA&period=max&api_key=YOUR_API_KEY